{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:23:35Z","timestamp":1787027015343,"version":"build-2736575974"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Postmenopausal osteoporosis (PMOP) is a serious condition that affects elderly individuals. Our previous study revealed that Yigu decoction (YGD) effectively improved bone mineral density (BMD) in elderly individuals, but the mechanism underlying this effect remains unclear. In this study, we investigated the relationships among YGD, microRNAs (miRNAs), and bone metabolism by assessing the effects of YGD on the miRNA levels in patient plasma to provide a scientific basis for treating PMOP with YGD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this clinical trial, 60 patients were randomly assigned to the YGD group or the control group (ratio of 1:1) and treated for 3\u00a0months. The primary outcome measure was BMD, and the secondary outcome measures included plasma miRNA levels, visual analogue scale (VAS) scores, alkaline phosphatase (ALP) levels, anti-tartrate acid phosphatase (TRACP-5b) levels and traditional Chinese medicine (TCM) syndrome scores. We assessed the regulatory roles of miRNAs in PMOP patients by analysing publicly available data from the Gene Expression Omnibus (GEO) database. Bioinformatics methods were also used to explore the mechanism by which YGD regulates miRNAs that are involved in bone metabolism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with those before treatment, the BMD, ALP levels, TRACP-5b levels, TCM syndrome scores and VAS scores improved in both groups after 3 months of treatment (P &amp;lt; 0.05). A total of 82 miRNAs differed between the groups. After analysing data from the GEO database, we confirmed that miR-133a-3p is the key molecule that mediates the effects of YGD intervention on PMOP. GO analysis of key genes suggested that gene enrichment was more pronounced in response to hormones, cellular response to growth factor stimulation, and positive regulation of physiological and metabolic processes. KEGG analysis revealed that these genes were enriched mainly in the PI3K-Akt, FOXO, and JAK-STAT pathways and other pathways. The results of the protein\u2012protein interaction (PPI) network analysis revealed that epidermal growth factor receptor (EGFR), Insulin-like growth factor 1 (IGF-1), Caveolin-1 (Cav-1) and others were core proteins.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study demonstrated that YGD is beneficial in the treatment of PMOP, ameliorating clinical symptoms and bone turnover indices. Moreover, the inhibition of miR-133a-3p expression may be the key mechanisms by which YGD regulates bone metabolism in the treatment of PMOP, although YGD regulates bone metabolism in a multitarget and multipathway manner.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2024.1460906","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T06:48:43Z","timestamp":1730875723000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Yigu decoction regulates plasma miRNA in postmenopausal osteoporosis patients: a randomized controlled trial"],"prefix":"10.3389","volume":"15","author":[{"given":"Haifeng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruikun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guijin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhineng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmiao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11626-020-00530-w","article-title":"Xian-Ling-Gu-Bao protects osteoporosis through promoting osteoblast differentiation by targeting miR-100-5p\/KDM6B\/RUNX2 axis","volume":"57","author":"Ai","year":"2021","journal-title":"Vitro Cell Dev. Biol. Anim."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1370900","DOI":"10.3389\/fphar.2024.1370900","article-title":"Traditional Chinese medicine in osteoporosis: from pathogenesis to potential activity","volume":"15","author":"Cao","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/gerona\/glt093","article-title":"Public health impact of osteoporosis","volume":"68","author":"Cauley","year":"2013","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e7586","DOI":"10.1136\/bmj.e7586","article-title":"Spirit 2013 explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e0184129","DOI":"10.1371\/journal.pone.0184129","article-title":"Prediction and analysis of essential genes using the enrichments of gene Ontology and kegg pathways","volume":"12","author":"Chen","year":"2017","journal-title":"PLoS One"},{"key":"B6","doi-asserted-by":"publisher","first-page":"5727","DOI":"10.18632\/aging.204172","article-title":"The therapeutic effect of Fufang Zhenshu Tiaozhi (FTZ) on osteoclastogenesis and ovariectomized-induced bone loss: evidence from network pharmacology, molecular docking and experimental validation","volume":"14","author":"Chen","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.16766\/j.cnki.issn.1674-4152.002116","article-title":"Study on the target and mechanism of Yigu Decoction in the prevention and treatment of osteoporosis based on network pharmacology","volume":"19","author":"Chen","year":"2021","journal-title":"Chin. J. General Pract."},{"key":"B8","first-page":"1","article-title":"Guidelines for diagnosis and treatment of postmenopausal osteoporosis (osteoporosis) in traditional Chinese medicine (2019 edition)","volume":"32","year":"2020","journal-title":"Orthop. Traditional Chin. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11657-017-0324-5","article-title":"UK clinical guideline for the prevention and treatment of osteoporosis","volume":"12","author":"Compston","year":"2017","journal-title":"Arch. Osteoporos."},{"key":"B10","doi-asserted-by":"publisher","first-page":"101782","DOI":"10.1016\/j.beem.2023.101782","article-title":"Bone health and menopause: osteoporosis prevention and treatment","volume":"38","author":"de Villiers","year":"2024","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1063899","DOI":"10.3389\/fphar.2022.1063899","article-title":"Kidney tonifying traditional Chinese medicine: potential implications for the prevention and treatment of osteoporosis","volume":"13","author":"Duan","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1471-2105-8-69","article-title":"Inference of mirna targets using evolutionary conservation and pathway analysis","volume":"8","author":"Gaidatzis","year":"2007","journal-title":"BMC Bioinforma."},{"key":"B13","doi-asserted-by":"publisher","first-page":"afac044","DOI":"10.1093\/ageing\/afac044","article-title":"New national osteoporosis guidance-implications for geriatricians","volume":"51","author":"Gregson","year":"2022","journal-title":"Age Ageing"},{"key":"B14","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1186\/s12885-020-06869-3","article-title":"Scdb: an integrated database of stomach cancer","volume":"20","author":"Gu","year":"2020","journal-title":"BMC Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1089\/cmb.2016.0093","article-title":"Analyzing the lncrna, mirna, and mrna regulatory network in prostate cancer with bioinformatics software","volume":"25","author":"He","year":"2018","journal-title":"J. Comput. Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"117224","DOI":"10.1016\/j.bone.2024.117224","article-title":"miR-18a-5p promotes osteogenic differentiation of BMSC by inhibiting Notch2","volume":"188","author":"He","year":"2024","journal-title":"Bone"},{"key":"B17","doi-asserted-by":"publisher","first-page":"g1687","DOI":"10.1136\/bmj.g1687","article-title":"Better reporting of interventions: template for intervention description and replication (tidier) checklist and guide","volume":"348","author":"Hoffmann","year":"2014","journal-title":"BMJ"},{"key":"B18","doi-asserted-by":"publisher","first-page":"D192","DOI":"10.1093\/nar\/gkaa1047","article-title":"Rfam 14: expanded coverage of metagenomic, viral and microrna families","volume":"49","author":"Kalvari","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.tem.2012.03.008","article-title":"Estrogen and the skeleton","volume":"23","author":"Khosla","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"B20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1471-213X-11-34","article-title":"Expression of mir-1, mir-133a, mir-133b and mir-206 increases during development of human skeletal muscle","volume":"11","author":"Koutsoulidou","year":"2011","journal-title":"BMC Dev. Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"D155","DOI":"10.1093\/nar\/gky1141","article-title":"Mirbase: from microrna sequences to function","volume":"47","author":"Kozomara","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"866641","DOI":"10.3389\/fendo.2022.866641","article-title":"Mechanism and experimental verification of luteolin for the treatment of osteoporosis based on network pharmacology","volume":"13","author":"Liang","year":"2022","journal-title":"Front. Endocrinol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.16466\/j.issn1005-5509.2018.02.001","article-title":"Effects of Yigu Decoction on wnt\/\u03b2-Catenin canonical signaling pathway in bone tissue of castrated rats","volume":"42","author":"Lin","year":"2018","journal-title":"J. Zhejiang Chin. Med. Univ."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/s41418-017-0054-7","article-title":"Egfr controls bone development by negatively regulating mtor-signaling during osteoblast differentiation","volume":"25","author":"Linder","year":"2018","journal-title":"Cell Death Differ."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.12659\/MSM.912801","article-title":"Identification of key circrnas\/lncrnas\/mirnas\/mrnas and pathways in preeclampsia using bioinformatics analysis","volume":"25","author":"Liu","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","article-title":"Microrna","volume":"141","author":"Lu","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"7440","DOI":"10.3748\/wjg.v23.i41.7440","article-title":"Circulating mirnas as biomarkers for severe acute pancreatitis associated with acute lung injury","volume":"23","author":"Lu","year":"2017","journal-title":"World J. Gastroenterology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.19288\/j.cnki.issn.1000-2723.2016.06.002","article-title":"Effects of Yi Bone Soup on bone mineral density and BMP-2 signalling pathway in osteoporotic rats","volume":"39","author":"L","year":"2016","journal-title":"J. Yunnan Coll. Traditional Chin. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1002\/jbmr.4097","article-title":"Unique, gender-dependent serum microrna profile in Pls3 gene-related osteoporosis","volume":"35","author":"Makitie","year":"2020","journal-title":"J. Bone Min. Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"W273","DOI":"10.1093\/nar\/gkp292","article-title":"Diana-microt web server: elucidating microrna functions through target prediction","volume":"37","author":"Maragkakis","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1359\/JBMR.050403","article-title":"Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover","volume":"20","author":"Nenonen","year":"2005","journal-title":"J. Bone Min. Res."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20190667","article-title":"Differentially expressed circulating mirnas in postmenopausal osteoporosis: a meta-analysis","volume":"39","author":"Pala","year":"2019","journal-title":"Biosci. Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1210\/jcem.85.9.6836","article-title":"Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60","volume":"85","author":"Peacock","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B34","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/s8756-3282(98)00183-5","article-title":"Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women. Alendronate Osteoporosis Prevention Study Group","volume":"24","author":"Ravn","year":"1999","journal-title":"Bone"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/S0140-6736(21)02646-5","article-title":"Drug therapy for osteoporosis in older adults","volume":"399","author":"Reid","year":"2022","journal-title":"Lancet"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1093\/nar\/gku631","article-title":"The multimir R package and database: integration of microrna-target interactions along with their disease and drug associations","volume":"42","author":"Ru","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.62347\/ZMAL4724","article-title":"The effects of alfacalcidol combined with calcitonin in the treatment of osteoporosis and its influence on levels of inflammation","volume":"16","author":"Rui","year":"2024","journal-title":"Am. J. Transl. Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s00198-015-3093-2","article-title":"Projection of osteoporosis-related fractures and costs in China: 2010-2050","volume":"26","author":"Si","year":"2015","journal-title":"Osteoporos. Int."},{"key":"B39","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5152\/eurjrheum.2016.048","article-title":"An overview and management of osteoporosis","volume":"4","author":"Sozen","year":"2017","journal-title":"Eur. J. Rheumatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"30 1","DOI":"10.1002\/cpbi.5","article-title":"The genecards suite: from gene data mining to disease genome sequence analyses","volume":"54","author":"Stelzer","year":"2016","journal-title":"Curr. Protoc. Bioinforma."},{"key":"B41","doi-asserted-by":"publisher","first-page":"165852","DOI":"10.1016\/j.bbadis.2020.165852","article-title":"Osteoclast signaling-targeting mir-146a-3p and mir-155-5p are downregulated in paget's disease of bone","volume":"1866","author":"Stephens","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s11658-019-0146-0","article-title":"Mir-125a-5p promotes osteoclastogenesis by targeting Tnfrsf1b","volume":"24","author":"Sun","year":"2019","journal-title":"Cell Mol. Biol. Lett."},{"key":"B43","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The string database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13046-018-0813-4","article-title":"Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K\/AKT signaling","volume":"37","author":"Tang","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"113085","DOI":"10.1016\/j.yexcr.2022.113085","article-title":"Icariin triggers osteogenic differentiation of bone marrow stem cells by up-regulating miR-335-5p","volume":"414","author":"Teng","year":"2022","journal-title":"Exp. Cell Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-1-62703-748-8_3","article-title":"The role of micrornas in human diseases","volume":"1107","author":"Tufekci","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10928-015-9423-3","article-title":"A semi-mechanistic model of bone mineral density and bone turnover based on a circular model of bone remodeling","volume":"42","author":"van Schaick","year":"2015","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"B48","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1142\/S0192415X24500393","article-title":"The role of traditional Chinese medicines in the treatment of osteoporosis","volume":"52","author":"Wang","year":"2024","journal-title":"Am. J. Chin. Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.biopha.2017.02.090","article-title":"Lncrna Meg3 inhibited osteogenic differentiation of bone marrow mesenchymal stem cells from postmenopausal osteoporosis by targeting mir-133a-3p","volume":"89","author":"Wang","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"B50","doi-asserted-by":"publisher","first-page":"839","DOI":"10.13288\/j.11-2166\/r.2022.09.009","article-title":"Guigui Zhuanggu Pian: a randomized, double-blind, placebo-controlled clinical study on the treatment of 150 postmenopausal osteoporosis patients with kidney yin and yang deficiency syndrome and back pain","volume":"63","author":"Weiyi","year":"2022","journal-title":"J. Traditional Chin. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12935-020-1098-1","article-title":"ZEB1-AS1\/miR-133a-3p\/LPAR3\/EGFR axis promotes the progression of thyroid cancer by regulating PI3K\/AKT\/mTOR pathway","volume":"20","author":"Xia","year":"2020","journal-title":"Cancer Cell Int."},{"key":"B52","first-page":"1027","article-title":"Clinical observation on the treatment of osteoporotic pain by traditional Chinese medicine Yi Bone Soup combined with Miguei Xieyi","volume":"25","author":"Y","year":"2015","journal-title":"Zhejiang J. Integr. Chin. West. Med."},{"key":"B53","first-page":"1","article-title":"Yigu Tang on nuclear factors in ovariectomized osteoporosis rats \u03ba the influence of B receptor activating factor ligand signaling pathway","volume":"30","author":"Yan","year":"","journal-title":"Chin. J. Orthop. Traumatology Traditional Chin. Med."},{"key":"B54","first-page":"675","article-title":"Clinical evaluation of Yigu Decoction in the treatment of senile osteoporosis","volume":"28","author":"Yan","year":"","journal-title":"Chin. J. Osteopor."},{"key":"B55","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/jcp.21511","article-title":"Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling","volume":"217","author":"Yi","year":"2008","journal-title":"J. Cell Physiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e23776","DOI":"10.1096\/fj.202400113RR","article-title":"Exploration of the miR-187-3p\/CNR2 pathway in modulating osteoblast differentiation and treating postmenopausal osteoporosis through mechanical stress","volume":"38","author":"Zhang","year":"2024","journal-title":"FASEB J."},{"key":"B57","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12014-021-09330-0","article-title":"Quantitative proteomics reveals the effect of Yigu decoction (ygd) on protein expression in bone tissue","volume":"18","author":"Zhang","year":"2021","journal-title":"Clin. Proteomics"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1091083","DOI":"10.3389\/fcimb.2023.1091083","article-title":"Anti-osteoporotic drugs affect the pathogenesis of gut microbiota and its metabolites: a clinical study","volume":"13","author":"Zhang","year":"2023","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B59","first-page":"1007","article-title":"Expert consensus on diagnostic criteria for osteoporosis in Chinese people (Third Draft, 2014 Edition)","volume":"20","author":"Zhang","year":"2014","journal-title":"Chin. J. Osteoporos."},{"key":"B60","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1261\/rna.074922.120","article-title":"Misuse of RPKM or TPM normalization when comparing across samples and sequencing protocols","volume":"26","author":"Zhao","year":"2020","journal-title":"RNA"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.3390\/diagnostics12112872","article-title":"Bone-metabolism-related serum micrornas to diagnose osteoporosis in middle-aged and elderly women","volume":"12","author":"Zhao","year":"2022","journal-title":"Diagn. (Basel)"},{"key":"B62","doi-asserted-by":"publisher","first-page":"253","DOI":"10.16466\/j.issn1005-5509.2016.04.005","article-title":"A multicenter randomized controlled clinical study of modified Yigu Decoction in the treatment of senile osteoporosis","volume":"40","author":"Zhengqing","year":"2016","journal-title":"J. Zhejiang Chin. Med. Univ."},{"key":"B63","doi-asserted-by":"publisher","first-page":"16661","DOI":"10.1002\/cam4.6270","article-title":"Cuproptosis-related mirnas signature and immune infiltration characteristics in colorectal cancer","volume":"12","author":"Zhu","year":"2023","journal-title":"Cancer Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"901545","DOI":"10.3389\/fendo.2022.901545","article-title":"Evolving roles of natural terpenoids from traditional Chinese medicine in the treatment of osteoporosis","volume":"13","author":"Zhuo","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1460906\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T06:48:50Z","timestamp":1730875730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1460906\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,6]]},"references-count":64,"alternative-id":["10.3389\/fphar.2024.1460906"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1460906","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,6]]},"article-number":"1460906"}}